These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 650812)
21. [Anticoagulant therapy of myocardial infarct]. Hilgard P Munch Med Wochenschr; 1971 Oct; 113(43):1411-4. PubMed ID: 5171218 [No Abstract] [Full Text] [Related]
22. Inhibitors of coagulation. Rangarajan S Haemophilia; 2011 Jan; 17(1):90-4. PubMed ID: 20546027 [No Abstract] [Full Text] [Related]
23. [Peroral anticoagulant therapy]. Dejanov I God Zb Med Fak Skopje; 1975; 21():215-21. PubMed ID: 1213525 [No Abstract] [Full Text] [Related]
24. New directions in anticoagulation. Alpert JS Am J Med; 2012 Mar; 125(3):217-8. PubMed ID: 22340912 [No Abstract] [Full Text] [Related]
25. [Hopes, joys and disappointments of surgeons in connection with the development of the blood coagulation problem]. Filatov AN Vestn Khir Im I I Grek; 1969 Aug; 103(8):3-10. PubMed ID: 5397112 [No Abstract] [Full Text] [Related]
26. [Thromboembolic risk prevention in surgical procedures]. Cupa M; Chevrel JP; Lapandry C Anesth Analg (Paris); 1974; 31(5):753-66. PubMed ID: 4460782 [No Abstract] [Full Text] [Related]
32. [Defibrination syndrome: treatment with an antifibrinolytic drug and anticoagulants]. Mannucci PM; Lobina G; Biggio P; Caocci L; Congiu P Clin Ter; 1967 Oct; 43(1):19-33. PubMed ID: 4884577 [No Abstract] [Full Text] [Related]
33. [Clinical and pharmacoeconomic aspects. Selection criteria for anticoagulants]. Lipp HP Pharm Unserer Zeit; 2004; 33(3):220-8. PubMed ID: 15208910 [No Abstract] [Full Text] [Related]
34. [Therapeutic defibrination--a new principle of anticoagulant therapy]. Voss D Internist (Berl); 1968 Sep; 9(9):389-90. PubMed ID: 4918659 [No Abstract] [Full Text] [Related]
35. [Thromboembolism. Principles, possibilities, and prospects of success of specific prophylaxis (author's transl)]. Netzer CO MMW Munch Med Wochenschr; 1975 Sep; 117(36):1397-404. PubMed ID: 809682 [TBL] [Abstract][Full Text] [Related]
36. [Bleeding time in long-term anticoagulant therapy]. Serradimigni A; Arnoux E; Giraud M; Audier M Angeiologie; 1967; 19(5):49-52. PubMed ID: 5621973 [No Abstract] [Full Text] [Related]
37. Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban. Morell J; Sullivan B; Khalabuda M; McBride BF J Clin Pharmacol; 2010 Sep; 50(9):986-1000. PubMed ID: 20124518 [TBL] [Abstract][Full Text] [Related]
38. [Antifibrinolytic agents and anticoagulants in disseminated intravascular coagulation, with particular regard to embolism of the amniotic fluid and hemorrhage in gynecology]. Koutský J Cesk Gynekol; 1971 Apr; 36(3):140-1. PubMed ID: 5314511 [No Abstract] [Full Text] [Related]
39. Fatal rebound hypertension after abrupt withdrawal of clonidine and propranolol. Vernon C; Sakula A Br J Clin Pract; 1979 Apr; 33(4):112, 121. PubMed ID: 475954 [No Abstract] [Full Text] [Related]
40. [Use of anticoagulant in continuous hemodiafiltration therapy]. Odaka M Nihon Rinsho; 1991 Dec; 49 Suppl():468-71. PubMed ID: 1808302 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]